245 related articles for article (PubMed ID: 23373094)
1. Herpes zoster vaccine. Poorly effective in those who need it most.
Prescrire Int; 2012 Dec; 21(133):291. PubMed ID: 23373094
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of herpes zoster by vaccination].
Kofoed K; Rønholt F; Gerstoft J; Sand C
Ugeskr Laeger; 2011 Jan; 173(2):110-4. PubMed ID: 21219841
[TBL] [Abstract][Full Text] [Related]
3. [Zoster vaccine].
Wutzler P
Klin Monbl Augenheilkd; 2010 May; 227(5):384-7. PubMed ID: 20490991
[TBL] [Abstract][Full Text] [Related]
4. Vaccination: a new option to reduce the burden of herpes zoster.
Mick G
Expert Rev Vaccines; 2010 Mar; 9(3 Suppl):31-5. PubMed ID: 20192716
[TBL] [Abstract][Full Text] [Related]
5. Vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia.
Betts RF
J Am Acad Dermatol; 2007 Dec; 57(6 Suppl):S143-7. PubMed ID: 18021866
[TBL] [Abstract][Full Text] [Related]
6. [Active immunoprophylaxis to reduce clinical impact of Herpes Zoster and its complications].
Marino MG; Bagnato B; Torella I; Franco E
Ig Sanita Pubbl; 2009; 65(3):299-311. PubMed ID: 19629155
[TBL] [Abstract][Full Text] [Related]
7. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
Holcomb K; Weinberg JM
J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
[TBL] [Abstract][Full Text] [Related]
8. Vaccination to prevent herpes zoster in older adults.
Gnann JW
J Pain; 2008 Jan; 9(1 Suppl 1):S31-6. PubMed ID: 18166463
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of vaccination of the elderly against herpes zoster in The Netherlands.
de Boer PT; Pouwels KB; Cox JM; Hak E; Wilschut JC; Postma MJ
Vaccine; 2013 Feb; 31(9):1276-83. PubMed ID: 23306360
[TBL] [Abstract][Full Text] [Related]
10. [Herpes zoster and postherpetic neuralgia - prevention by vaccination?].
Wutzler P
Dtsch Med Wochenschr; 2009 Apr; 134 Suppl 2():S90-4. PubMed ID: 19353479
[TBL] [Abstract][Full Text] [Related]
11. Herpes zoster virus vaccine.
Woolery WA
Geriatrics; 2008 Oct; 63(10):6-9. PubMed ID: 18828650
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Pellissier JM; Brisson M; Levin MJ
Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
[TBL] [Abstract][Full Text] [Related]
13. Herpes zoster vaccine: clinical trial evidence and implications for medical practice.
Burke MS
J Am Osteopath Assoc; 2007 Mar; 107(3 Suppl 1):S14-8. PubMed ID: 17488883
[TBL] [Abstract][Full Text] [Related]
14. A novel vaccine (Zostavax) to prevent herpes zoster.
Holcomb K; Weinberg JM
G Ital Dermatol Venereol; 2008 Apr; 143(2):119-23. PubMed ID: 18833038
[TBL] [Abstract][Full Text] [Related]
15. [Pain in herpes zoster: Prevention and treatment].
Calvo-Mosquera G; González-Cal A; Calvo-Rodríguez D; Primucci CY; Plamenov-Dipchikov P
Semergen; 2017; 43(4):318-327. PubMed ID: 27053513
[TBL] [Abstract][Full Text] [Related]
16. Safety and tolerability of a high-potency zoster vaccine in adults >/= 50 or years of age.
Tyring SK; Diaz-Mitoma F; Padget LG; Nunez M; Poland G; Cassidy WM; Bundick ND; Li J; Chan IS; Stek JE; Annunziato PW;
Vaccine; 2007 Feb; 25(10):1877-83. PubMed ID: 17227688
[TBL] [Abstract][Full Text] [Related]
17. Zostavax : a subcutaneous vaccine for the prevention of herpes zoster.
Doan HQ; Ung B; Ramirez-Fort MK; Khan F; Tyring SK
Expert Opin Biol Ther; 2013 Oct; 13(10):1467-77. PubMed ID: 23984934
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the incidence of herpes zoster after concomitant administration of zoster vaccine and polysaccharide pneumococcal vaccine.
Tseng HF; Smith N; Sy LS; Jacobsen SJ
Vaccine; 2011 May; 29(20):3628-32. PubMed ID: 21435407
[TBL] [Abstract][Full Text] [Related]
19. Live zoster vaccination in an immunocompromised patient leading to death secondary to disseminated varicella zoster virus infection.
Alexander KE; Tong PL; Macartney K; Beresford R; Sheppeard V; Gupta M
Vaccine; 2018 Jun; 36(27):3890-3893. PubMed ID: 29807711
[TBL] [Abstract][Full Text] [Related]
20. Update on herpes zoster vaccine: licensure for persons aged 50 through 59 years.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Nov; 60(44):1528. PubMed ID: 22071592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]